Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acid
production is negative from all carbohydrate substrates
tested.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (Shkoporov2015)
DNA G+C(%): 56.6
|
Bile reaction(%): 20(neg)
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: Sens
ampicillin: Res
cloxacillin: Sens
oxacillin: Sens
penicillin_G: Sens
|
cefoperazone: Res
cefoxitin: Res
ceftazidime: Sens
cefuroxime: Res
cephalothin: Sens
|
amikacin: Sens
gentamicin: Sens
neomycin: Sens
|
azithromycin: Res
roxithromycin: Sens
|
linezolid: Sens
ciprofloxacin: Res
levofloxacin: Sens
moxifloxacin: Sens
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
deoxycycline: Res
|
vancomycin: Sens
|
|
chloramphenicol: Res
metronidazole: Sens
co-trimoxazole: Res
|
clindamycin: Sens
fusidic-acid: Sens
|